1650 - Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap

Saturday, October 22, 2022

10:45 AM – 11:00 AM US ET

Location: 144 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Kamilia Abdelraouf, PhD

Associate Director
Hartford Hospital
Hartofrd, CT, United States

Disclosure: Disclosure(s): Evopoint Biosciences Co., Ltd: Grant/Research Support (); Venatorx Pharmaceuticals, Inc.: Grant/Research Support ()

Slides

Co-Author(s)

Christian M. Gill, PharmD

Infectious Diseases Pharmacy Fellow
Hartford Hospital
Hartford, Connecticut, United States

Disclosure: Disclosure(s): Everest Medicines, Shionogi, Cepheid: Grant/Research Support ()
MG

Matthew Gethers, PhD

Hartford Hospital
Hartford, Connecticut, United States

Disclosure: Disclosure(s): Thermo Fisher: Employee ()
GT

Giusy Tiseo, MD

Infectious Diseases Unit/University of Pisa
Pisa, Toscana, Italy

Disclosure: Disclosure(s): No financial relationships to disclose
MF

Marco Falcone, MD, PhD

Infectious Diseases Unit/University of Pisa
Pisa, Toscana, Italy

Disclosure: Disclosure(s): GILEAD: Grant/Research Support (); GSK: Honoraria (); MENARINI: Advisor/Consultant (), Grant/Research Support (); MSD: Honoraria (); PFIZER: Honoraria (); SHIONOGI: Grant/Research Support ()
FM

Francesco Menichetti, n/a

Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Pisa, Pisa, Italy
Pisa, Toscana, Italy

Disclosure: Disclosure(s): Aneglini: Advisor/Consultant (), Board Member (), Grant/Research Support (), Honoraria (); Astellas: Advisor/Consultant (), Honoraria (); Becton: Advisor/Consultant (), Honoraria (); bioMérieux: Advisor/Consultant (), Honoraria (); Biotest: Advisor/Consultant (), Board Member (), Honoraria (); Bristol-Myers Squibb: Advisor/Consultant (), Honoraria (); Correvio: Advisor/Consultant (), Speaker honoraria (); Dickinson: Advisor/Consultant (), Honoraria (); Gilead: Advisor/Consultant (), Grant/Research Support (); Janssen: Advisor/Consultant (), Honoraria (); MSD: Advisor/Consultant (), Speaker honoraria (); Nordic pharma: Board Member (), Honoraria (); Pfizer: Advisor/Consultant (), Honoraria (); Shionogi: Advisor/Consultant (), Honoraria (); ViiV: Advisor/Consultant (), Honoraria ()
DN

David P. Nicolau, PharmD

Director
Hartford Hospital
Hartford, Connecticut, United States

Disclosure: Disclosure(s): Shionogi: Grant/Research Support ()

Disclosure(s):

Kamilia Abdelraouf, PhD: Evopoint Biosciences Co., Ltd: Grant/Research Support (); Venatorx Pharmaceuticals, Inc.: Grant/Research Support ()

Christian M. Gill, PharmD: Everest Medicines, Shionogi, Cepheid: Grant/Research Support ()

Matthew Gethers, PhD: Thermo Fisher: Employee ()

Giusy Tiseo, MD: No financial relationships to disclose

Marco Falcone, MD, PhD: GILEAD: Grant/Research Support (); GSK: Honoraria (); MENARINI: Advisor/Consultant (), Grant/Research Support (); MSD: Honoraria (); PFIZER: Honoraria (); SHIONOGI: Grant/Research Support ()

Francesco Menichetti, n/a: Aneglini: Advisor/Consultant (), Board Member (), Grant/Research Support (), Honoraria (); Astellas: Advisor/Consultant (), Honoraria (); Becton: Advisor/Consultant (), Honoraria (); bioMérieux: Advisor/Consultant (), Honoraria (); Biotest: Advisor/Consultant (), Board Member (), Honoraria (); Bristol-Myers Squibb: Advisor/Consultant (), Honoraria (); Correvio: Advisor/Consultant (), Speaker honoraria (); Dickinson: Advisor/Consultant (), Honoraria (); Gilead: Advisor/Consultant (), Grant/Research Support (); Janssen: Advisor/Consultant (), Honoraria (); MSD: Advisor/Consultant (), Speaker honoraria (); Nordic pharma: Board Member (), Honoraria (); Pfizer: Advisor/Consultant (), Honoraria (); Shionogi: Advisor/Consultant (), Honoraria (); ViiV: Advisor/Consultant (), Honoraria ()

David P. Nicolau, PharmD: Shionogi: Grant/Research Support ()